Entity
  • OXB

    Created in 1995


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    54,421 3,098
  • Activities

  • Technologies

  • Entity types

  • Location

    Windrush Court, Watlington Rd, Oxford OX4 6LT, UK

    Oxford

    United Kingdom

  • Employees

    Scale: 501-1000

    Estimated: 934

  • Engaged catalyst

    20
    0 0
  • Added in Motherbase

    4 years, 3 months ago
Description
  • Value proposition

    OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.

    One of the original pioneers in cell and gene therapy, OXB has over 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

    OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVectaTM system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.

    OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US. Learn more at www.oxb.com and follow us on LinkedIn and YouTube.

    Gene therapy, Immunotherapy, Viral vector GMP manufacturing, Cell and gene therapy, Lentiviral Vectors, AAV, Cell therapy, CDMO, GMP, Process Development, Manufacturing, and Advanced Therapies

  • Let’s deliver life-changing therapies together - OXB

    25+ years enabling the world’s most progressive and successful viral vector therapies. Full service offering, supported by robust quality systems.

  • https://oxb.com/
Catalyst interactions
Catalyst Type Tweets Articles
Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto)
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto)
Other

27 Jul 2026


Ville et Eurométropole de Strasbourg
Ville et Eurométropole de Strasbourg
National and local authorities, Government Administration (Auto), French Metropolis
Ville et Eurométropole de Strasbourg
National and local authorities, Government Administration (Auto), French Metropolis
Other

1 Jul 2024


BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology (Auto)
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology (Auto)
Other

24 Mar 2026


Oxford University Innovation
Oxford University Innovation
Research, Investment Management (Auto)
Oxford University Innovation
Research, Investment Management (Auto)
Other

22 May 2024


IP Group plc
IP Group plc
Financial Services (Auto)
IP Group plc
Financial Services (Auto)
Other

30 Jun 2023


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing (Auto)
MSD
Pharmaceutical, Pharmaceutical Manufacturing (Auto)
Other

2 Dec 2020


UK Research and Innovation
UK Research and Innovation
Public business cluster, Research Services (Auto)
UK Research and Innovation
Public business cluster, Research Services (Auto)
Other

6 May 2021


Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research (Auto)
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research (Auto)
Other

12 Jun 2020


Raytheon
Raytheon
Biotechnology, Defense and Space Manufacturing (Auto)
Raytheon
Biotechnology, Defense and Space Manufacturing (Auto)
Other

29 Apr 2019


Apple
Apple
Consumer Electronics, Computers and Electronics Manufacturing (Auto)
Apple
Consumer Electronics, Computers and Electronics Manufacturing (Auto)
Other

8 Jun 2018


Social network dynamics
Similar entities
BETA
Loading...
Loading...